Compounds > 1-(5-isoquinolinesulfonyl)-2-methylpiperazine
Page last updated: 2024-10-28

1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Proliferative Vitreoretinopathy

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Proliferative Vitreoretinopathy in 2 studies

1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kita, T2
Hata, Y1
Arita, R1
Kawahara, S1
Miura, M1
Nakao, S1
Mochizuki, Y1
Enaida, H1
Goto, Y1
Shimokawa, H1
Hafezi-Moghadam, A1
Ishibashi, T1

Reviews

1 review available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Proliferative Vitreoretinopathy

ArticleYear
[Molecular mechanisms of preretinal membrane contraction in proliferative vitreoretinal diseases and ROCK as a therapeutic target].
    Nippon Ganka Gakkai zasshi, 2010, Volume: 114, Issue:11

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Diabetic Retinopathy; Molecular Targeted The

2010

Other Studies

1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Proliferative Vitreoretinopathy

ArticleYear
Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target.
    Proceedings of the National Academy of Sciences of the United States of America, 2008, Nov-11, Volume: 105, Issue:45

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Actins; Animals; Blotting, Western; Immunohistochemis

2008